Literature DB >> 24621938

Racial/Ethnic differences in B-type natriuretic peptide levels and their association with care and outcomes among patients hospitalized with heart failure: findings from Get With The Guidelines-Heart Failure.

Selim R Krim1, Rey P Vivo2, Nassim R Krim3, Feng Qian4, Margueritte Cox5, Hector Ventura6, Adrian F Hernandez5, Deepak L Bhatt7, Gregg C Fonarow8.   

Abstract

OBJECTIVES: This study sought to determine if there were differences in B-type natriuretic peptide (BNP) levels across racial/ethnic groups and in their association with quality of care and in-hospital outcomes among patients with heart failure (HF).
BACKGROUND: It remains unclear whether BNP levels and their associations with quality of care and prognosis vary by race/ethnicity among patients hospitalized with HF.
METHODS: Using Get With The Guidelines-Heart Failure (GWTG-HF), patient characteristics and BNP levels at admission were compared among 4 racial/ethnic populations: white, black, Hispanic, and Asian. The associations between BNP, quality of care, in-hospital mortality, and length of stay (LOS) across these groups were analyzed.
RESULTS: A total of 92,072 patients (65,037 white, 19,092 black, 6,747 Hispanic, and 1,196 Asian) from 264 hospitals were included. Median BNP levels were higher in Asian (1,066 pg/ml) and black (866 pg/ml) patients than in white (776 pg/ml) and Hispanic (737 pg/ml) patients, and race/ethnicity was independently associated with BNP levels (p < 0.0001). Irrespective of race/ethnicity, patients in higher BNP quartiles (Q3, Q4) were more likely to be older and male and have lower body mass index, reduced ejection fraction, and renal insufficiency, whereas those in the lowest quartile (Q1) were more likely to have diabetes. With some exceptions, there were no significant racial/ethnic differences in the association of BNP levels with performance measure adherence. In multivariate analysis, elevated BNP levels remained associated with longer LOS and increased mortality in all racial/ethnic groups.
CONCLUSIONS: Asian and black patients with HF had higher BNP levels at admission compared with white and Hispanic patients. BNP levels at admission provided prognostic value for in-hospital mortality and hospital LOS irrespective of race/ethnicity.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BNP; heart failure; outcome; quality of care; race

Mesh:

Substances:

Year:  2013        PMID: 24621938     DOI: 10.1016/j.jchf.2013.04.008

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  21 in total

Review 1.  Practical Pharmacogenomic Approaches to Heart Failure Therapeutics.

Authors:  Chayakrit Krittanawong; Amalia Namath; David E Lanfear; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-10

2.  Racial/ethnic differences in the prognostic utility of left ventricular mass index for incident cardiovascular disease.

Authors:  Emmanuel Akintoye; Karim Mahmoud; Mohamed Shokr; Aubin Sandio; Sagar Mallikethi-Reddy; Muhammad Sheikh; Oluwole Adegbala; Alexander Egbe; Alexandros Briasoulis; Luis Afonso
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

Review 3.  Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group.

Authors:  Sean Collins; Alan B Storrow; Nancy M Albert; Javed Butler; Justin Ezekowitz; G Michael Felker; Gregory J Fermann; Gregg C Fonarow; Michael M Givertz; Brian Hiestand; Judd E Hollander; David E Lanfear; Phillip D Levy; Peter S Pang; W Frank Peacock; Douglas B Sawyer; John R Teerlink; Daniel J Lenihan
Journal:  J Card Fail       Date:  2014-07-18       Impact factor: 5.712

4.  Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease?

Authors:  Eileen M Hsich; Joseph G Rogers; Dennis M McNamara; David O Taylor; Randall C Starling; Eugene H Blackstone; Jesse D Schold
Journal:  JACC Heart Fail       Date:  2016-05-11       Impact factor: 12.035

Review 5.  Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group.

Authors:  Sean P Collins; Alan B Storrow; Phillip D Levy; Nancy Albert; Javed Butler; Justin A Ezekowitz; G Michael Felker; Gregory J Fermann; Gregg C Fonarow; Michael M Givertz; Brian Hiestand; Judd E Hollander; David E Lanfear; Peter S Pang; W Frank Peacock; Douglas B Sawyer; John R Teerlink; Daniel J Lenihan
Journal:  Acad Emerg Med       Date:  2014-11-25       Impact factor: 3.451

6.  The influence of age on the clinical implications of N-terminal pro-B-type natriuretic peptide in acute coronary syndrome.

Authors:  Fang-Yang Huang; Bao-Tao Huang; Jia-Yu Tsauo; Yong Peng; Tian-Li Xia; Chen Zhang; Rui-Shuang Liu; Zhi-Liang Zuo; Peng-Ju Wang; Yue Heng; Wei Liu; Xiao-Bo Pu; Yi-Yue Gui; Shi-Jian Chen; Yan-Biao Liao; Ye Zhu; Mao Chen
Journal:  Intern Emerg Med       Date:  2016-06-25       Impact factor: 3.397

Review 7.  A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.

Authors:  Gary S Francis; G Michael Felker; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2016-01-26       Impact factor: 24.094

Review 8.  Cardiac natriuretic peptides.

Authors:  Jens P Goetze; Benoit G Bruneau; Hugo R Ramos; Tsuneo Ogawa; Mercedes Kuroski de Bold; Adolfo J de Bold
Journal:  Nat Rev Cardiol       Date:  2020-05-22       Impact factor: 32.419

9.  Associations of adiponectin and leptin with brain natriuretic peptide in African Americans: the Jackson Heart Study.

Authors:  Steven R Horbal; Michael E Hall; Paul C Dinh; Abbas Smiley; Solomon K Musani; Jiankang Liu; Herman A Taylor; Ervin R Fox; Aurelian Bidulescu
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-15

10.  Active B-Type Natriuretic Peptide Measured by Mass Spectrometry and Response to Sacubitril/Valsartan.

Authors:  Erica M Dillon; Shouzuo D Wei; Deepak K Gupta; Hui Nian; Brooks S Rodibaugh; Katherine N Bachmann; Allen J Naftilan; Lynne W Stevenson; Nancy J Brown
Journal:  J Card Fail       Date:  2021-06-13       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.